| dc.contributor.author | Kovář, Ondřej | |
| dc.contributor.author | Finger, Vladimír | |
| dc.contributor.author | Kufa, Martin | |
| dc.contributor.author | Roh, Jaroslav | |
| dc.contributor.author | Korábečný, Jan | |
| dc.date.accessioned | 2025-04-16T12:10:41Z | |
| dc.date.available | 2025-04-16T12:10:41Z | |
| dc.date.issued | 2024 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14178/3078 | |
| dc.description.abstract | Tuberculosis TB is a globally prevalent infectious disease caused by Mycobacterium tuberculosis (Mtb). We developed a straightforward synthesis of C215 and its derivatives and established a basic pharmacological profile. | en |
| dc.language.iso | en | |
| dc.publisher | Česká společnost chemická | |
| dc.relation.url | http://www.ccsss.cz/index.php/ccsss/issue/view/48 | |
| dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
| dc.rights | Creative Commons Attribution 4.0 International | en |
| dc.title | Structural Insights and Functional Impact of the MmpL3 Inhibitor C215 | en |
| dcterms.accessRights | openAccess | |
| dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
| dc.date.updated | 2025-04-16T14:40:52Z | |
| dc.subject.keyword | Tuberculosis | en |
| dc.publisher.publicationPlace | Praha | |
| dc.identifier.eissn | 2336-7210 | |
| dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
| dc.relation.fundingReference | info:eu-repo/grantAgreement/UK/GAUK/GAUK238323 | |
| dc.relation.fundingReference | info:eu-repo/grantAgreement/UK/COOP/COOP | |
| dc.date.embargoStartDate | 2025-04-16 | |
| dc.type.obd | 110 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.obd | 664891 | |
| dc.subject.rivPrimary | 30000::30100::30104 | |
| dcterms.isPartOf.name | Czech Chemical Society Symposium Series | |
| dcterms.isPartOf.issn | 2336-7202 | |
| dcterms.isPartOf.journalYear | 2024 | |
| dcterms.isPartOf.journalVolume | 22 | |
| dcterms.isPartOf.journalIssue | 6 | |
| uk.faculty.primaryId | 113 | |
| uk.faculty.primaryName | Farmaceutická fakulta v Hradci Králové | cs |
| uk.faculty.primaryName | Faculty of Pharmacy in Hradec Kralove | en |
| uk.faculty.secondaryId | 51 | |
| uk.faculty.secondaryName | Fakultní nemocnice Hradec Králové | cs |
| uk.faculty.secondaryName | University Hospital Hradec Králové | en |
| uk.department.primaryId | 113 | |
| uk.department.primaryName | Farmaceutická fakulta v Hradci Králové | cs |
| uk.department.primaryName | Faculty of Pharmacy in Hradec Kralove | en |
| uk.department.secondaryId | 366 | |
| uk.department.secondaryId | 5000002805 | |
| uk.department.secondaryName | Katedra organické a bioorganické chemie | cs |
| uk.department.secondaryName | Department of Organic and Bioorganic Chemistry | en |
| uk.department.secondaryName | Centrum biomedicínského výzkumu | cs |
| uk.department.secondaryName | Biomedical Research Center | en |
| uk.event.name | NIVB Meeting 2024: The third annual meeting of the National Institute of Virology and Bacteriology | |
| dc.description.pageRange | 247-247 | |
| dc.type.obdHierarchyCs | ABSTRAKT::abstrakt::abstrakt v konferenčním sborníku | cs |
| dc.type.obdHierarchyEn | ABSTRACT::abstract::abstract in conference proceedings | en |
| dc.type.obdHierarchyCode | 110::130::462 | en |
| uk.displayTitle | Structural Insights and Functional Impact of the MmpL3 Inhibitor C215 | en |
